Development Level

Tbio 17 | 11,445
Tchem 3 | 1,598

IMPC Phenotype

abnormal bone structure 1 | 187
increased heart weight 1 | 62
increased startle reflex 1 | 112

Disease

glioblastoma 14 | 5,792
medulloblastoma, large-cell 13 | 6,241
ependymoma 11 | 4,679
Astrocytoma, Pilocytic 10 | 3,081
Carcinoma 10 | 11,493
adult high grade glioma 10 | 3,801
oligodendroglioma 10 | 2,850
ovarian cancer 10 | 8,520
atypical teratoid / rhabdoid tumor 9 | 5,112
group 4 medulloblastoma 9 | 1,855
lung carcinoma 9 | 2,843
osteosarcoma 9 | 7,950
psoriasis 9 | 6,694
astrocytic glioma 8 | 2,597
lung cancer 7 | 4,740
non-small cell lung cancer 7 | 2,890
Breast cancer 6 | 3,578
Schizophrenia 6 | 1,160
intraductal papillary-mucinous carcinoma (IPMC) 6 | 2,989
malignant mesothelioma 6 | 3,232
pancreatic cancer 6 | 2,398
primitive neuroectodermal tumor 6 | 3,035
subependymal giant cell astrocytoma 6 | 2,287
ulcerative colitis 6 | 1,819
group 3 medulloblastoma 5 | 4,104
invasive ductal carcinoma 5 | 2,951
lung adenocarcinoma 5 | 2,716
non primary Sjogren syndrome sicca 5 | 891
pituitary cancer 5 | 1,972
tuberculosis 5 | 2,010
Liver Cirrhosis, Experimental 4 | 769
Pick disease 4 | 1,894
interstitial cystitis 4 | 2,312
Atopic dermatitis 3 | 952
Down syndrome 3 | 499
Kidney cancer 3 | 2,613
breast carcinoma 3 | 1,638
colon cancer 3 | 1,478
intraductal papillary-mucinous adenoma (IPMA) 3 | 2,955
Crohn's disease 2 | 321
Essential Hypertension 2 | 94
Hypertension 2 | 396
Hypertensive disease 2 | 292
Kidney disease 2 | 430
Marijuana Abuse 2 | 31
Multiple Sclerosis 2 | 540
Night Blindness 2 | 101
Obesity 2 | 678
Parkinson's disease 2 | 392
active ulcerative colitis 2 | 764
astrocytoma 2 | 1,146
chronic lymphosyte leukemia 2 | 204
cutaneous lupus erythematosus 2 | 1,057
cystic fibrosis 2 | 1,696
dermatomyositis 2 | 966
ductal carcinoma in situ 2 | 1,745
esophageal adenocarcinoma 2 | 737
head and neck cancer 2 | 271
hepatocellular carcinoma 2 | 547
intraductal papillary-mucinous neoplasm (IPMN) 2 | 3,291
non-small cell lung carcinoma 2 | 317
pancreatic carcinoma 2 | 562
pediatric high grade glioma 2 | 1,064
periodontitis 2 | 293
posterior fossa group B ependymoma 2 | 416
primary Sjogren syndrome 2 | 735
severe Alzheimer's disease 2 | 47
spina bifida 2 | 1,074
urothelial carcinoma 2 | 318
Acromegaly 1 | 51
Adenoma 1 | 167
Alcoholic Intoxication, Chronic 1 | 289
Amphetamine-Related Disorders 1 | 74
Arsenic Poisoning 1 | 62
Breast Neoplasms 1 | 445
Cushing's syndrome 1 | 48
Dermatologic disorders 1 | 93
Disease of anatomical entity 1 | 32
Dyskinesia, Drug-Induced 1 | 15
Hyperphosphatemia 1 | 32
Hypertrophic Cardiomyopathy 1 | 117
Hypothyroidism 1 | 122
Liver cancer 1 | 604
Low Vision 1 | 174
Mammary Neoplasms 1 | 425
Melanoma 1 | 711
Mood Disorders 1 | 184
Nephrolithiasis 1 | 56
Pain agnosia 1 | 104
Photodysphoria 1 | 121
Photophobia 1 | 121
Pituitary adenoma 1 | 38
Skin Diseases 1 | 71
Skin cancer 1 | 469
Stomach Neoplasms 1 | 300
Visual Impairment 1 | 174
cystic fibrosis and chronic rhinosinusitis 1 | 214
facioscapulohumeral dystrophy 1 | 288
posterior fossa group A ependymoma 1 | 468
substance-related disorder 1 | 162

Tissue

Blood and immune system 19 | 16,909
Endocrine System 19 | 18,159
Female tissues 19 | 17,400
Skin and soft tissues 19 | 17,230
Digestive Tract 18 | 17,369
Liver and Pancreas 18 | 16,750
Male tissues 18 | 17,142
Nervous System 18 | 16,725
Respiratory system 17 | 16,393
Urinary Tract 17 | 16,678
Cardiovascular System 16 | 15,192

Target Family

Non-IDG 20 | 12,091

PathwayCommons: inoh Pathway

http://pathwaycommons.org/pc2/... 20 | 20
http://pathwaycommons.org/pc2/... 236 | 236
http://pathwaycommons.org/pc2/... 235 | 235
http://pathwaycommons.org/pc2/... 233 | 233
http://pathwaycommons.org/pc2/... 224 | 224
http://pathwaycommons.org/pc2/... 224 | 224
http://pathwaycommons.org/pc2/... 223 | 223
http://pathwaycommons.org/pc2/... 223 | 223
http://pathwaycommons.org/pc2/... 183 | 183
http://pathwaycommons.org/pc2/... 178 | 178
http://pathwaycommons.org/pc2/... 173 | 173
http://pathwaycommons.org/pc2/... 173 | 173
http://pathwaycommons.org/pc2/... 123 | 123
http://pathwaycommons.org/pc2/... 96 | 96
http://pathwaycommons.org/pc2/... 85 | 85
http://pathwaycommons.org/pc2/... 63 | 63
http://pathwaycommons.org/pc2/... 60 | 60
http://pathwaycommons.org/pc2/... 58 | 58
http://pathwaycommons.org/pc2/... 56 | 56
http://pathwaycommons.org/pc2/... 56 | 56
http://pathwaycommons.org/pc2/... 56 | 56
http://pathwaycommons.org/pc2/... 56 | 56
http://pathwaycommons.org/pc2/... 56 | 56
http://pathwaycommons.org/pc2/... 55 | 55
http://pathwaycommons.org/pc2/... 51 | 51
http://pathwaycommons.org/pc2/... 49 | 49
http://pathwaycommons.org/pc2/... 48 | 48
http://pathwaycommons.org/pc2/... 47 | 47
http://pathwaycommons.org/pc2/... 47 | 47
http://pathwaycommons.org/pc2/... 47 | 47
http://pathwaycommons.org/pc2/... 47 | 47
http://pathwaycommons.org/pc2/... 47 | 47
http://pathwaycommons.org/pc2/... 47 | 47
http://pathwaycommons.org/pc2/... 45 | 45
http://pathwaycommons.org/pc2/... 44 | 44
http://pathwaycommons.org/pc2/... 43 | 43
http://pathwaycommons.org/pc2/... 43 | 43
http://pathwaycommons.org/pc2/... 42 | 42
http://pathwaycommons.org/pc2/... 40 | 40
http://pathwaycommons.org/pc2/... 40 | 40
http://pathwaycommons.org/pc2/... 40 | 40
http://pathwaycommons.org/pc2/... 40 | 40
http://pathwaycommons.org/pc2/... 38 | 38
http://pathwaycommons.org/pc2/... 37 | 37
http://pathwaycommons.org/pc2/... 36 | 36
http://pathwaycommons.org/pc2/... 36 | 36
http://pathwaycommons.org/pc2/... 35 | 35
http://pathwaycommons.org/pc2/... 35 | 35
http://pathwaycommons.org/pc2/... 35 | 35
http://pathwaycommons.org/pc2/... 34 | 34
http://pathwaycommons.org/pc2/... 30 | 30
http://pathwaycommons.org/pc2/... 30 | 30
http://pathwaycommons.org/pc2/... 29 | 29
http://pathwaycommons.org/pc2/... 29 | 29
http://pathwaycommons.org/pc2/... 28 | 28
http://pathwaycommons.org/pc2/... 27 | 27
http://pathwaycommons.org/pc2/... 27 | 27
http://pathwaycommons.org/pc2/... 24 | 24
http://pathwaycommons.org/pc2/... 24 | 24
http://pathwaycommons.org/pc2/... 24 | 24
http://pathwaycommons.org/pc2/... 24 | 24
http://pathwaycommons.org/pc2/... 24 | 24
http://pathwaycommons.org/pc2/... 24 | 24
http://pathwaycommons.org/pc2/... 22 | 22
http://pathwaycommons.org/pc2/... 21 | 21
http://pathwaycommons.org/pc2/... 21 | 21
http://pathwaycommons.org/pc2/... 21 | 21
http://pathwaycommons.org/pc2/... 21 | 21
http://pathwaycommons.org/pc2/... 20 | 20
http://pathwaycommons.org/pc2/... 20 | 20
http://pathwaycommons.org/pc2/... 20 | 20
http://pathwaycommons.org/pc2/... 19 | 19
http://pathwaycommons.org/pc2/... 19 | 19
http://pathwaycommons.org/pc2/... 19 | 19
http://pathwaycommons.org/pc2/... 19 | 19
http://pathwaycommons.org/pc2/... 19 | 19
http://pathwaycommons.org/pc2/... 19 | 19
http://pathwaycommons.org/pc2/... 19 | 19
http://pathwaycommons.org/pc2/... 19 | 19
http://pathwaycommons.org/pc2/... 19 | 19
http://pathwaycommons.org/pc2/... 19 | 19
http://pathwaycommons.org/pc2/... 18 | 18
http://pathwaycommons.org/pc2/... 18 | 18
http://pathwaycommons.org/pc2/... 18 | 18
http://pathwaycommons.org/pc2/... 18 | 18
http://pathwaycommons.org/pc2/... 18 | 18
http://pathwaycommons.org/pc2/... 18 | 18
http://pathwaycommons.org/pc2/... 18 | 18
http://pathwaycommons.org/pc2/... 17 | 17
http://pathwaycommons.org/pc2/... 17 | 17
http://pathwaycommons.org/pc2/... 17 | 17
http://pathwaycommons.org/pc2/... 17 | 17
http://pathwaycommons.org/pc2/... 17 | 17
http://pathwaycommons.org/pc2/... 16 | 16
http://pathwaycommons.org/pc2/... 16 | 16
http://pathwaycommons.org/pc2/... 16 | 16
http://pathwaycommons.org/pc2/... 16 | 16
http://pathwaycommons.org/pc2/... 16 | 16
http://pathwaycommons.org/pc2/... 16 | 16
http://pathwaycommons.org/pc2/... 15 | 15

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Regulator of G-protein signaling 14 RGS14 Tbio Non-IDG -1.61170 43.9 233
Regulator of G-protein signaling 11 RGS11 Tbio Non-IDG -1.68422 46.9 111
Regulator of G-protein signaling 16 RGS16 Tbio Non-IDG -1.61831 43.3 185
Regulator of G-protein signaling 10 RGS10 Tbio Non-IDG -1.42892 32.0 146
Regulator of G-protein signaling 19 RGS19 Tchem Non-IDG -1.71216 50.4 385
Regulator of G-protein signaling 12 RGS12 Tbio Non-IDG -1.39356 26.7 69
Regulator of G-protein signaling 18 RGS18 Tbio Non-IDG -1.51586 35.8 142
Regulator of G-protein signaling 17 RGS17 Tbio Non-IDG -1.36519 22.6 111
Regulator of G-protein signaling 2 RGS2 Tbio Non-IDG -2.36297 251.2 199
Regulator of G-protein signaling 20 RGS20 Tbio Non-IDG -1.29481 20.0 117